Literature DB >> 9878201

Regional specificity of brain atrophy in Huntington's disease.

G M Halliday1, D A McRitchie, V Macdonald, K L Double, R J Trent, E McCusker.   

Abstract

The present study analyzes the relationship between cortical and subcortical brain volumes in patients with Huntington's disease. The brains of seven patients with a clinical diagnosis and positive family history of Huntington's disease and 12 controls were collected at autopsy with consent from relatives. Detailed clinical assessments were available for all study subjects with genotype confirmation for patients with Huntington's disease. Volume analysis of the brain on serial 3-mm coronal slices was performed as previously described. All patients with Huntington's disease exhibited significant brain atrophy resulting from volume reductions in both cortical and subcortical grey matter. Atrophy of the cortex was relatively uniform, although the medial temporal lobe structures were spared. The caudate nucleus and putamen were strikingly reduced in all cases and this atrophy correlated with the severity of cortical atrophy, suggesting an associated disease process. The rate of cortical but not subcortical atrophy correlated with CAG repeat numbers. Loss of frontal white matter correlated with both cortical and striatal atrophy. Age of onset of chorea correlated with the amount of subcortical atrophy, while duration of chorea correlated negatively with atrophy of the white matter. These results suggest a more widespread and global disease process in patients with Huntington's disease. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9878201     DOI: 10.1006/exnr.1998.6919

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  67 in total

1.  Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.

Authors:  Aaron C Rising; Jia Xu; Aaron Carlson; Vincent V Napoli; Eileen M Denovan-Wright; Ronald J Mandel
Journal:  Exp Neurol       Date:  2010-12-28       Impact factor: 5.330

2.  A Case of Previously Unsuspected Huntington Disease Diagnosed at Autopsy.

Authors:  Catherine R Miller; Nobby C Mambo; Jianli Dong; Gerald A Campbell
Journal:  Acad Forensic Pathol       Date:  2017-03-01

3.  Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

4.  Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease.

Authors:  Yi-Yu Chou; Natasha Leporé; Greig I de Zubicaray; Owen T Carmichael; James T Becker; Arthur W Toga; Paul M Thompson
Journal:  Neuroimage       Date:  2007-12-08       Impact factor: 6.556

5.  Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.

Authors:  Susie M D Henley; Edward J Wild; Nicola Z Hobbs; Rachael I Scahill; Gerard R Ridgway; David G Macmanus; Roger A Barker; Nick C Fox; Sarah J Tabrizi
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

Review 6.  The influence of cannabinoids on generic traits of neurodegeneration.

Authors:  S G Fagan; V A Campbell
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 7.  The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease.

Authors:  Aris A Polyzos; Cynthia T McMurray
Journal:  Mech Ageing Dev       Date:  2016-09-12       Impact factor: 5.432

8.  Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease.

Authors:  Jeffrey C L Looi; Priya Rajagopalan; Mark Walterfang; Sarah K Madsen; Paul M Thompson; Matthew D Macfarlane; Chris Ching; Phyllis Chua; Dennis Velakoulis
Journal:  Aust N Z J Psychiatry       Date:  2012-09-18       Impact factor: 5.744

9.  Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

Authors:  Eduardo E Arteaga-Bracho; Maria Gulinello; Michael L Winchester; Nandini Pichamoorthy; Jenna R Petronglo; Alicia D Zambrano; Julio Inocencio; Chirstopher D De Jesus; Joseph O Louie; Solen Gokhan; Mark F Mehler; Aldrin E Molero
Journal:  Neurobiol Dis       Date:  2016-09-10       Impact factor: 5.996

Review 10.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.